AN INVESTIGATION OF THE RELATIONSHIP BETWEEN THE eNOS GENE POLYMORPHISM AND DIAGNOSED MIGRAINE
Güler S1,*, Gürkan H2, Tozkir H2, Turan N3, Çelik Y1
*Corresponding Author: Sibel Güler, M.D., Department of Neurology, Trakya University Faculty of Medicine, Balkan Yerleşkesi, 22030 Edirne, Turkey. Tel: +90-284-236-49-81. Fax: +90-284-223-42-03. E-mail: drsibleguler@ yahoo.com
page: 49

INTRODUCTION

Migraine is a neurological disease that affects approximately 12.0-16.0% of the population. It leads to specific disabling conditions and has a genetic component [1]. Despite its high prevalence, the complex pathogenetic mechanisms of migraine remain unclear. However, the significance of nitric oxide (NO) in migraine pathogenesis has been reported in some studies. In essence, NO plays an important role in cerebral blood flow regulation and is involved in the activation of nociceptors in the trigeminovascular system and the release of vasoactive neuropep-tides during the neurogenic inflammatory response [2,3] causing vascular homeostasis, blocking of platelet adhesion and aggregation, inhibition of migration and proliferation of leukocyte and vascular muscle cells [4]. Thus, NO makes a significant contribution to antiatherogenic features in the endothelium. According to recent studies, genes encoding endothelial function regulators are indicated as significant candidate genes in individuals susceptible to migraine. Therefore, it has been claimed that gene polymorphisms for endothelial nitric oxide synthase gene (eNOS), are possible genetic factors involved in migraine [2]. It has been indicated that there is a strong association between NO and the pathophysiology of migraine and aura [5]. During the headache phase, an increase of platelets and administration of NO as an exogen makes the headache worse [5]. A Glu 268Asp amino acid change and point mutation (G894T, rs1799983) leads to a guanine to thymine change on exon 7 and nucleotide (nt) 894 in the eNOS gene, and this is related to reduced basal NO production. Another polymorphism (–786T>C, rs1800779) leads to a thymine to cytosine change on the eNOS 5’ promoter region –786 nt, which causes a reduction of both eNOS gene promoter activity and basal NO production [2]. To date, the studies investigating the association between migraine and eNOS gene polymorphisms have focused on eNOS rs743506, rs2070744, rs1799983, rs180079, rs3918226, rs207468799 and rs148554851 [5]. We believe that it is important to determine the genetic basis of the common primary headache that leads to migraine, since the latter creates disabling circumstances for people with regard to their social and working life. Therefore, we investigated phenotype- genotype association between eNOS rs743506, rs2070744, rs1799983, rs180079, rs3918226, rs207468799 and rs148554851 gene polymorphisms, which we suggest are candidate markers of susceptibility to migraine with and without aura.



Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006